Docosahexaenoic Acid (DHA) Market Trends

  • Report ID: 3946
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Docosahexaenoic Acid (DHA) Market - Growth Drivers and Challenges

Growth Drivers

  • Increase in Unhealthy Eating Habits - Unhealthy eating practices encompass undereating or overeating, not getting enough of the essential nutrients we need every day, or taking an excessive amount of low-fiber, high-fat, and sugar-containing foods and beverages. Such kind of food items deliver more harm to our overall health and even increases the death toll.
    The surge in unhealthy eating habits has been increasing the tendency to consume DHA as dietary supplements to get the required amount of essential nutrients for overall health, which is projected to fuel market growth. According to a global report, in 2021, nearly 49% of people ate either too little or too much.

  • Rising Disposable Income – Disposable income naturally leads to a growth in consumption. Based on Bureau of Economic Analysis data, by March 2022, personal income and disposable personal income (DPI) in the United States climbed by 107.2 billion and USD 89.7 billion respectively.

Challenges

  • Associated Side Effects of Docosahexaenoic Acid (DHA) - Though DHA is safe and very beneficial for the overall health of a person. But still, some rising side effects of DHA comprising headache, bad breath, bad taste, bloating, and so on are anticipated to limit people from consuming products containing docosahexaenoic acid. Moreover, taking DHA in the form of fish oil can also have a variety of side effects, such as heartburn, and nausea. Hence, this factor is anticipated to dampen the market growth over the projected time frame.

  • Unstable Supply of Raw Materials

  • High Cost of Concentrated DHA


Base Year

2025

Forecast Year

2026-2035

CAGR

9.9%

Base Year Market Size (2025)

USD 5.25 billion

Forecast Year Market Size (2035)

USD 13.49 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of docosahexaenoic acid is assessed at USD 5.72 billion.

The global docosahexaenoic acid market size was valued at over USD 5.25 billion in 2025 and is expected to expand at a CAGR of around 9.9%, surpassing USD 13.49 billion revenue by 2035.

The Asia Pacific region is forecasted to command a 42% share by 2035 in the docosahexaenoic acid (DHA) market, impelled by escalating healthcare expenditure that is heightening awareness of DHA’s health benefits.

Key players in the market include Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos